Suchergebnisse - (Subject:"pseudovirus")

PubPharm (11)

1

Comparison of antibody persistency through one year between one-dose and two-dose regimens of Ad5-nCoV vaccine for COVID-19

enthalten in: Human vaccines & immunotherapeutics | 2023

von Feng, J. | Wang, W. | Jin, P. | +7

2

Establishment of national standard for anti-SARS-Cov-2 neutralizing antibody in China : The first National Standard calibration traceability to the WHO International Standard

enthalten in: Frontiers in immunology | 2023

von Guan, L. | Mao, Q. | Tan, D. | +16

3

An Escherichia coli Expressed Multi-Disulfide Bonded SARS-CoV-2 RBD Shows Native-like Biophysical Properties and Elicits Neutralizing Antisera in a Mouse Model

enthalten in: International journal of molecular sciences | 2022

von Brindha, S. | Yoshizue, T. | Wongnak, R. | +4

4

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial

enthalten in: The Journal of infectious diseases | 2022

von El Sahly, H. | Baden, L. | Essink, B. | +21

5

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants

enthalten in: Cell | 2022

von Servellita, V. | Syed, A. | Morris, M. | +21

6

Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS-CoV-2 Variants after Primary and Booster Immunization

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2022

von Xie, H. | Wen, X. | Li, J. | +9

7

Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection

enthalten in: Cell reports. Medicine | 2022

von Pradenas, E. | Trinité, B. | Urrea, V. | +19

8

Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods

enthalten in: Current medical science | 2021

von Banga Ndzouboukou, J. | Zhang, Y. | Fan, X.

9

SARS‑CoV-2 RBD219-N1C1 : A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice

enthalten in: Human vaccines & immunotherapeutics | 2021

von Pollet, J. | Chen, W. | Versteeg, L. | +17

UpdateOf: bioRxiv. 2021 Feb 09;:. - PMID 33173864

10

Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals

enthalten in: Viruses | 2021

von Trinité, B. | Pradenas, E. | Marfil, S. | +24